Purchase Order HHSN275201800199P

Award Date 3/2/18
Potential Completion Date 4/2/18
Potential Value $2.4K
Ultimate Awardee
Bruker Corporation
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Bruker Biospin Corp, a subsidiary of Bruker Corporation, is for the procurement of scientific instrumentation and equipment. The $6,500 firm-fixed-price purchase order, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), was for the delivery of unspecified Bruker products by December 29, 2017. The award did not utilize any set-aside designations, indicating Bruker Biospin Corp competed openly for this contract. As a leading...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The $127,490.00 firm-fixed-price contract is for the delivery of a TCI CryoProbeTM for an Avance 600 MHz spectrometer. This purchase order contract does not have a set-aside designation. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The $322,000.00 firm fixed-price purchase order is for the delivery of scientific instrumentation, primarily nuclear magnetic resonance (NMR) spectrometers, magnetic resonance imaging (MRI) systems, and electron spin resonance (EPR) spectrometers. This award was not set aside and was competed...
This federal contract award, valued at $14,409.02, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of an ATM unit for probe Z151032/0001, with a completion date of September 30, 2023. The contract type is a Purchase Order with a Firm Fixed Price pricing structure. This award was not designated as a set-aside contract. Bruker Corporation is a global scientific...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Bruker Biospin Corp, a subsidiary of the Bruker Corporation. The $203,775.00 firm-fixed-price purchase order was awarded on September 10, 2016 with a completion date of September 18, 2017. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance,...
This federal contract award, valued at $440,500.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a manufacturer of scientific instruments. The award is for the purchase of an AVANCE III HD 600 console, as described in the associated quote. The end user is Gideon Clore, and the contract does not have a set-aside designation. Bruker Biospin Corp is known to provide nuclear magnetic resonance spectrometers, upgrades, maintenance,...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, to acquire a service contract for a CryoPlatform system. The $216,845.10 contract will be performed in Billerica, Massachusetts and has an ultimate completion date of September 27, 2023. The contract was awarded on September 28, 2022, and did not utilize any set-aside designations. The original...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $216,684 firm-fixed price purchase order to Bruker Biospin Corp. for a CryoPlatformTM Maintenance Agreement. This agreement will provide critical maintenance services for the agency's Nuclear Magnetic Resonance (NMR) spectrometers used in protein research. Bruker Biospin Corp. is the sole source provider of the proprietary CryoPlatform equipment and authorized maintenance services. This purchase order does...
This federal contract award, valued at $14,409.02, was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the procurement of an Automated Tube Measurement (ATM) module for an NIH probe. This purchase order is a firm fixed-price contract with a completion date of November 1, 2023. The award did not utilize any set-aside designations. Bruker Biospin Corp is a manufacturer of scientific...
This is a non-competitive, single-source $152,119.10 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp for annual service and maintenance of seven Bruker CryoPlatform NMR spectrometer systems. The contract covers remote diagnosis, repairs, and scheduled overhaul maintenance to ensure the continued operation of these critical scientific instruments used for protein structure and interaction research...

This federal contract award is for the repair of a 700 MHz Model Z151032 cryoprobe by Bruker Biospin Corp, a subsidiary of Bruker Corporation. The $2,350 firm fixed-price purchase order was awarded on March 2, 2018, with an ultimate completion date of April 2, 2018. The contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH). Bruker Biospin Corp is an experienced provider of scientific instrumentation and maintenance services to federal agencies, and has engaged in collaborative research partnerships through grants. This contract did not have a set-aside designation, indicating Bruker competed openly for the award.

Generated 4/18/25, 2:01 AM